This is not the most recent version of the article. View current version (1 MAY 2014)

Intervention Review

Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion

  1. Tasanee Braithwaite1,*,
  2. Afshan A Nanji2,
  3. Paul B Greenberg3

Editorial Group: Cochrane Eyes and Vision Group

Published Online: 6 OCT 2010

Assessed as up-to-date: 9 AUG 2010

DOI: 10.1002/14651858.CD007325.pub2


How to Cite

Braithwaite T, Nanji AA, Greenberg PB. Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion. Cochrane Database of Systematic Reviews 2010, Issue 10. Art. No.: CD007325. DOI: 10.1002/14651858.CD007325.pub2.

Author Information

  1. 1

    Moorfields Eye Hospital NHS Foundation Trust, London, UK

  2. 2

    Johns Hopkins University School of Medicine, Wilmer Eye Institute, Baltimore, Maryland, USA

  3. 3

    Warren Alpert Medical School of Brown University, Division of Ophthalmology, Providence, Rhode Island, USA

*Tasanee Braithwaite, Moorfields Eye Hospital NHS Foundation Trust, 162 City Road, London, EC1V 2PD, UK. tasaneebraithwaite@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 6 OCT 2010

SEARCH

This is not the most recent version of the article. View current version (01 MAY 2014)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Shuangwen Zhou, Jianping Gao, Xun Xu, Antivascular endothelial growth factors in the treatment of macular oedema secondary to central retinal vein occlusion: a meta-analysis, Clinical & Experimental Ophthalmology, 2014, 42, 7
  2. 2
    Jin-Wei Cheng, Shi-Wei Cheng, Rui-Li Wei, Guo-Cai Lu, Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery, The Cochrane Library,
  3. 3
    Tasanee Braithwaite, Afshan A Nanji, Kristina Lindsley, Paul B Greenberg, Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion, The Cochrane Library,